drugset / Trial / NCT01336582
Pharmacokinetic Study of SYP-0704A and Taxotere to Treat Patient With Advanced Solid Cancer
RandomizedCrossoverOpen-labelTreatment
Summary
Primary Objective: Evaluation of the pharmacokinetic equivalence of two Docetaxel formulations in terms of AUC and Cmax.
Timeline
- Start
- 2009-08
- Primary completion
- 2012-04
- Completion
- 2012-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Docetaxel | Small molecule | 70 mg/m2 | — |
| Subject | Docetaxel | Small molecule | 75 mg/m2 | — |